A DNA vaccine encoding the outer surface protein C from Borrelia burgdorferi is able to induce protective immune responses

Microbes and Infection

Volumn 5, Issue 11, 2003, Pages 939-946

  Scheiblhofer, Sandra ^a   Weiss, Richard ^a   Dürnberger, Hans ^a   Mostböck, Sven ^a   Breitenbach, Michael ^a   Livey, Ian ^b   Thalhamer, Josef ^a  

^a UNIVERSITY OF SALZBURG   (Austria)

^b BAXTER INNOVATIONS GMBH   (Austria)

Author keywords

DNA vaccines; Gene gun technique; Lyme borreliosis

Indexed keywords

DNA VACCINE; OUTER SURFACE PROTEIN C; PLASMID DNA; RECOMBINANT PROTEIN; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; BORRELIA BURGDORFERI; BORRELIA INFECTION; CONTROLLED STUDY; CPG ISLAND; FEMALE; GENE GUN; IMMUNE RESPONSE; INJECTION; LYME DISEASE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN MOTIF; TH1 CELL; TH2 CELL;

BORRELIA; BORRELIA BURGDORFERI; SPIROCHAETALES;

EID: 0043198261     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(03)00182-5     Document Type: Article

References (33)

1. Sigal L.H. Lyme disease: a review of aspects of its immunology and immunopathogenesis. Annu. Rev. Immunol. 15:1997;63-92.
2. Schwan T.G., Piesman J., Golde W.T., Dolan M.C., Rosa P.A. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc. Natl. Acad. Sci. USA. 7:1995;2909-2913.
3. de Silva A.M., Telford S.R., Brunet L.R., Barthold S.W., Fikrig E. Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. J. Exp. M. 1:1996;271-275.
4. Barthold S.W., Bockenstedt L.K. Passive immunizing activity of sera from mice infected with Borrelia burgdorferi. Infect. Immun. 11:1993;4696-4702.
5. Golde W.T., Kappel K.J., Dequesne G., Feron C., Plainchamp D., Capiau C., Lobet Y. Tick transmission of Borrelia burgdorferi to inbred strains of mice induces an antibody response to P39 but not to outer surface protein A. Infect. Immun. 6:1994;2625-2627. (published erratum appears in Infect. Immun. 63 [3] [1995] 1146).
6. de Silva A.M., Zeidner N.S., Zhang Y., Dolan M.C., Piesman J., Fikrig E. Influence of outer surface protein A antibody on Borrelia burgdorferi within feeding ticks. Infect. Immun. 1:1999;30-35.
7. Montgomery R.R., Malawista S.E., Feen K.J., Bockenstedt L.K. Direct demonstration of antigenic substitution of Borrelia burgdorferi ex vivo: exploration of the paradox of the early immune response to outer surface proteins A and C in Lyme disease. J. Exp. M. 1:1996;261-269.
8. Carroll J.A., Garon C.F., Schwan T.G. Effects of environmental pH on membrane proteins in Borrelia burgdorferi. Infect. Immun. 7:1999;3181-3187.
9. Bockenstedt L.K., Hodzic E., Feng S., Bourrel K.W., de Silva A., Montgomery R.R., Fikrig E., Radolf J.D., Barthold S.W. Borrelia burgdorferi strain-specific Osp C-mediated immunity in mice. Infect. Immun. 11:1997;4661-4667.
10. Gilmore R.D. Jr, Kappel K.J., Dolan M.C., Burkot T.R., Johnson B.J. Outer surface protein C (OspC), but not P39, is a protective immunogen against a tick-transmitted Borrelia burgdorferi challenge: evidence for a conformational protective epitope in OspC. Infect. Immun. 6:1996;2234-2239.
11. Probert W.S., LeFebvre R.B. Protection of C3H/HeN mice from challenge with Borrelia burgdorferi through active immunization with OspA, OspB, or OspC, but not with OspD or the 83-kDa antigen. Infect. Immun. 5:1994;1920-1926.
12. Zhong W., Stehle T., Museteanu C., Siebers A., Gern L., Kramer M., Wallich R., Simon M.M. Therapeutic passive vaccination against chronic Lyme disease in mice. Proc. Natl. Acad. Sci. USA. 23:1997;12533-12538.
13. Zhong W., Gern L., Stehle T., Museteanu C., Kramer M., Wallich R., Simon M.M. Resolution of experimental and tick-borne Borrelia burgdorferi infection in mice by passive, but not active immunization using recombinant OspC. Eur. J. Immunol. 3:1999;946-957.
14. Probert W.S., Crawford M., Cadiz R.B., LeFebvre R.B. Immunization with outer surface protein (Osp) A, but not OspC, provides cross-protection of mice challenged with North American isolates of Borrelia burgdorferi. J. Infect. Dis. 2:1997;400-405.
15. Livey I., Gibbs C.P., Schuster R., Dorner F. Evidence for lateral transfer and recombination in OspC variation in Lyme disease Borrelia. Mol. Microbiol. 2:1995;257-269.
16. Jauris-Heipke S., Liegl G., Preac-Mursic V., Rossler D., Schwab E., Soutschek E., Will G., Wilske B. Molecular analysis of genes encoding outer surface protein C (OspC) of Borrelia burgdorferi sensu lato: relationship to ospA genotype and evidence of lateral gene exchange of ospC. J. Clin. Microbiol. 7:1995;1860-1866.
17. Donnelly J.J., Ulmer J.B., Shiver J.W., Liu M.A. DNA vaccines. Annu. Rev. Immunol. 15:1997;617-648.
18. Zhong W., Wiesmuller K.H., Kramer M.D., Wallich R., Simon M.M. Plasmid DNA and protein vaccination of mice to the outer surface protein A of Borrelia burgdorferi leads to induction of T helper cells with specificity for a major epitope and augmentation of protective IgG antibodies in vivo. Eur. J. Immunol. 11:1996;2749-2757.
19. Simon M.M., Gern L., Hauser P., Zhong W., Nielsen P.J., Kramer M.D., Brenner C., Wallich R. Protective immunization with plasmid DNA containing the outer surface lipoprotein A gene of Borrelia burgdorferi is independent of an eukaryotic promoter. Eur. J. Immunol. 12:1996;2831-2840.
20. Luke C.J., Carner K., Liang X., Barbour A.G. An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi. J. Infect. Dis. 1:1997;91-97.
21. Weiss R., Durnberger J., Mostbock S., Scheiblhofer S., Hartl A., Breitenbach M., Strasser P., Dorner F., Livey I., Crowe B., Thalhamer J. Improvement of the immune response against plasmid DNA encoding OspC of Borrelia by an ER-targeting leader sequence. Vaccine. 9-10:1999;815-824.
22. Weiss R., Leitner W.W., Scheiblhofer S., Chen D., Bernhaupt A., Mostbock S., Thalhamer J., Lyon J.A. Genetic vaccination against malaria infection by intradermal and epidermal injections of a plasmid containing the gene encoding the Plasmodium berghei circumsporozoite protein. Infect. Immun. 10:2000;5914-5919.
23. Feltquate D.M., Heaney S., Webster R.G., Robinson H.L. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J. Immunol. 5:1997;2278-2284.
24. Wallich R., Siebers A., Jahraus O., Brenner C., Stehle T., Simon M.M. DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but not for resolution of Lyme disease. Infect. Immun. 4:2001;2130-2136.
25. Sato Y., Roman M., Tighe H., Lee D., Corr M., Nguyen M.D., Silverman G.J., Lotz M., Carson D.A., Raz E. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science. 5273:1996;352-354.
26. Krieg A.M., Yi A.K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., Koretzky G.A., Klinman D.M. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature. 6522:1995;546-549.
27. Barry M.A., Johnston S.A. Biological features of genetic immunization. Vaccine. 8:1997;788-791.
28. Weiss R., Scheiblhofer S., Freund J., Ferreira F., Livey I., Thalhamer J. Gene gun bombardment with gold particles displays a particular Th2-promoting signal that overrules the Th1-inducing effect of immunostimulatory CpG motifs in DNA vaccines. Vaccine. 20:2002;3148-3154.
29. Klinman D.M., Yamshchikov G., Ishigatsubo Y. Contribution of CpG motifs to the immunogenicity of DNA vaccines. J. Immunol. 8:1997;3635-3639.
30. Threadgill D.S., McCormick L.L., McCool T.L., Greenspan N.S., Schreiber J.R. Mitogenic synthetic polynucleotides suppress the antibody response to a bacterial polysaccharide. Vaccine. 1:1998;76-82.
31. Hartl A., Kiesslich J., Weiss R., Bernhaupt A., Mostbock S., Scheiblhofer S., Ebner C., Ferreira F., Thalhamer J. Immune responses after immunization with plasmid DNA encoding Bet v 1, the major allergen of birch pollen. J. Allergy Clin. Immunol. 1:(Pt. 1):1999;107-113.
32. Hochreiter R., Hartl A., Freund J., Valenta R., Ferreira F., Thalhamer J. The influence of CpG motifs on a protein or DNA-based Th2-type immune response against major pollen allergens Bet v 1a, Phl p 2 and Escherichia coli-derived β-galactosidase. Int. Arch. Allergy Immunol. 1-3:2001;406-410.
33. Brtko J., Mostbock S., Scheiblhofer S., Hartl A., Thalhamer J. DNA immunization is associated with increased activity of type I iodothyronine 5′-deiodinase in mouse liver. Mol. Cell. Endocrinol. 1-2:1999;85-89.